I 
114TH CONGRESS 
2D SESSION 
H. R. 4983 
To provide information to prescribers in Federally qualified health centers 
and facilities of the Indian Health Service on best practices for pre-
scribing naloxone. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 18, 2016 
Mr. GRIFFITH introduced the following bill; which was referred to the Com-
mittee on Energy and Commerce, and in addition to the Committee on 
Natural Resources, for a period to be subsequently determined by the 
Speaker, in each case for consideration of such provisions as fall within 
the jurisdiction of the committee concerned 
A BILL 
To provide information to prescribers in Federally qualified 
health centers and facilities of the Indian Health Service 
on best practices for prescribing naloxone. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. PROVIDING INFORMATION TO PRESCRIBERS IN 
CERTAIN FEDERAL HEALTH CARE AND MED-
ICAL FACILITIES ON BEST PRACTICES FOR 
PRESCRIBING NALOXONE. 
(a) IN GENERAL.—Not later than 180 days after the 
date of enactment of this Act, the Secretary of Health and 
VerDate Sep 11 2014 
02:27 Apr 23, 2016
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4983.IH
H4983
SSpencer on DSK4SPTVN1PROD with BILLS
Human Services (in this section referred to as the ‘‘Sec-
retary’’) shall, as appropriate, provide information to pre-
scribers within Federally qualified health centers (as de-
fined in paragraph (4) of section 1861(aa) of the Social 
Security Act (42 U.S.C. 1395x(aa))), and the health care 
facilities of the Indian Health Service, on best practices 
for prescribing naloxone for patients receiving chronic 
opioid therapy, patients being treated for opioid use dis-
orders, and other patients that a provider identifies as 
having an elevated risk of overdose from heroin or pre-
scription opioid therapies. 
(b) NOT ESTABLISHING A MEDICAL STANDARD OF 
CARE.—The information on best practices provided under 
this section shall not be construed as constituting or estab-
lishing a medical standard of care for prescribing naloxone 
for patients described in subsection (a). 
(c) NO AUTHORIZATION OF ANY ADDITIONAL AP-
PROPRIATIONS.—The Secretary shall carry out this sec-
tion through funds otherwise appropriated and nothing in 
this section shall be construed as authorizing the appro-
priations of additional funds to carry out this section. 
(d) ELEVATED RISK OF OVERDOSE DEFINED.—In 
this section, the term ‘‘elevated risk of overdose’’ has the 
meaning given such term by the Secretary, which— 
VerDate Sep 11 2014 
02:27 Apr 23, 2016
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4983.IH
H4983
SSpencer on DSK4SPTVN1PROD with BILLS
(1) may be based on the criteria provided in the 
Opioid Overdose Toolkit published by the Substance 
Abuse and Mental Health Services Administration 
(SAMHSA); and 
(2) may include patients on a first course opioid 
treatment, patients using extended-release and long- 
acting opioid analgesic, and patients with a res-
piratory disease or other comorbidities. 
Æ 
VerDate Sep 11 2014 
02:27 Apr 23, 2016
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H4983.IH
H4983
SSpencer on DSK4SPTVN1PROD with BILLS